Stocks Comparison
Evolent Health vs Rentokil Initial: revenue, profit, margins and growth compared
Evolent Health brought in $1.9B of revenue in fiscal 2025, Rentokil Initial $6.9B in fiscal 2025. Revenue changed by -26.6% at Evolent Health and +4.4% at Rentokil Initial on the year before, so Rentokil Initial grew faster. Evolent Health kept -28.5% of its revenue as net profit, Rentokil Initial 6.8%.
Side by side, latest fiscal year
| EVH | RTO | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $1.9B | $6.9B |
| Revenue growth | -26.6% | +4.4% |
| Net income | -$534.5M | $470M |
| Net margin | -28.5% | 6.8% |
| Free cash flow | n/a | $764M |
| Free cash flow margin | n/a | 11.1% |
| Earnings per share (diluted) | -$5.07 | $0.19 |
| Cash | $151.9M | $2.3B |
| Debt | $970.5M | $5.4B |
| Price to earnings | n/a | n/a |
| Market value | $412.7M | $10.3B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #377 of 1065 · Consumer discretionary | #168 of 1065 · Consumer discretionary |
Over the years
Questions about Evolent Health and Rentokil Initial
Which is bigger by revenue, Evolent Health or Rentokil Initial?
Rentokil Initial is bigger by revenue: $6.9B in fiscal 2025, against $1.9B for Evolent Health in fiscal 2025.
Which keeps more of its revenue as profit, Evolent Health or Rentokil Initial?
Evolent Health had a net margin of -28.5% in fiscal 2025; Rentokil Initial had 6.8% in fiscal 2025.
Which grew revenue faster, Evolent Health or Rentokil Initial?
In their latest fiscal years revenue changed by -26.6% at Evolent Health and +4.4% at Rentokil Initial.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.